Labour induction for termination of pregnancy with severe fetal anomalies after 24 weeks’ gestation: a case series and systematic review of the literature

References

• Jatlaoui TC, Boutot ME, Mandel MG, et al. Abortion surveillance—United States 2015. MMWR Surveill Summ. 2018;67(13):1–45.
   PubMedGoogle Scholar
• National Academies of Sciences, Engineering and Medicine, Health, et al. The safety and quality of abortion care in the United States. Washington (DC): National Academies Press; 2018.
   Google Scholar
• American College of Obstetricians and Gynecologists. ACOG practice bulletin number 135, second trimester abortion. Washington DC: The College; 2013.
   Google Scholar
• Raymond EG, Grimes DA. The comparative safety of legal induced abortion and childbirth in the United States. Obstet Gynecol. 2012;119(2 Pt 1):215–219.
   PubMed Web of Science ®Google Scholar
• Perritt JB, Burke A, Edelman AB. Interruption of nonviable pregnancies of 24-28 weeks’ gestation using medical methods. Contraception. 2013;88(3):341–349.
   PubMed Web of Science ®Google Scholar
• WHO Guidelines Approved by the Guidelines Review Committee. Safe abortion: technical and policy guidance for health systems. Geneva: World Health Organization; 2012.
   Google Scholar
• Cayrac M, Faillie JL, Flandrin A, et al. Second- and third-trimester management of medical termination of pregnancy and fetal death in utero after prior caesarean section. Eur J Obstet Gynecol Reprod Biol. 2011;157(2):145–149.
   PubMed Web of Science ®Google Scholar
• Hoffer MC, Charlier C, Giacalone PL, et al. Evaluation of combination RU 486-laminaria tents-misoprostol-peridural anesthesia in second and third trimester induced abortions. J Gynecol Obstet Hum Reprod. 1998;27:83–86.
   Google Scholar
• Mazouni C, Vejux N, Menard J-P, et al. Cervical preparation with laminaria tents improves induction-to-delivery interval in second- and third-trimester medical termination of pregnancy. Contraception. 2009;80(1):101–104.
   PubMed Web of Science ®Google Scholar
• Sharp A, Navaratnam K, Abreu P, et al. Short versus standard mifepristone and misoprostol regimen for second- and third-trimester termination of pregnancy for fetal anomaly. Fetal Diagn Ther. 2016;39(2):140–146.
   PubMedGoogle Scholar
• Wingo E, Raifman S, Landau C, et al. Mifepristone-misoprostol versus misoprostol-alone regimen for medication abortion at ≥24 weeks’ gestation. Contraception. 2020;102(2):99–103.
   PubMedGoogle Scholar
• Borgatta L, Kapp N, Society of Family Planning Clinical guideline. Labour induction abortion in the second trimester. Contraception. 2011;84(1):4–18.
   PubMed Web of Science ®Google Scholar
• Reproductive Health Act. 775 ILCS 55. 2021. https://www.ilga.gov/legislation/ilcs/ilcs5.asp?ActID=3987&ChapterID=64
   Google Scholar
• American College of Obstetricians and Gynecologists. ACOG practice bulletin number 183, postpartum haemorrhage. Washington (DC): The College; 2017.
   Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
   PubMed Web of Science ®Google Scholar
• Mazouni C, Provensal M, Porcu G, et al. Termination of pregnancy in patients with previous cesarean section. Contraception. 2006;73(3):244–248.
   PubMed Web of Science ®Google Scholar
• Jannet D, Aflak N, Abankwa A, et al. Termination of 2nd and 3rd trimester pregnancies with mifepristone and misoprostol. Eur J Obstet Gynecol Reprod Biol. 1996;70(2):159–163.
   PubMedGoogle Scholar
• De Heus R, Graziosi GC, Christiaens GC, et al. Medical management for termination of second and third trimester pregnancies: a comparison of strategies. Eur J Obstet Gynecol Reprod Biol. 2004;116(1):16–21.
   PubMedGoogle Scholar
• Bertholdt C, David MG, Gabriel P, et al. Effect of the addition of osmotic dilators to medical induction of labour abortion: a before-and-after study. Eur J Obstet Gynecol Repro Biol. 2020;244:185–189.
   PubMedGoogle Scholar
• Vincienne M, Anselem O, Cordier A, et al. Comparison of the induction-to-delivery interval in terminations of pregnancy with or without Dilapan-S®. Fetal Diagn Ther. 2018;43(1):61–67.
   PubMed Web of Science ®Google Scholar
• Vlad S, Boucoiran I, St-Pierre ÉR, et al. Mifepristone-misoprostol use for second and third trimester medical termination of pregnancy in a Canadian tertiary care Centre. J Obstet Gynaecol Can. 2022;44(6):683–689.
   PubMedGoogle Scholar
• Prodan N, Breisch J, Hoopman M, et al. Dosing interval between mifepristone and misoprostol in second and third trimester termination. Arch Gynecol Obstet. 2019;299(3):675–679.
   PubMed Web of Science ®Google Scholar
• Dodd J, Crowther CA. Misoprostol for induction of labour to terminate pregnancy in the second or third trimester for women with a fetal anomaly or after intrauterine fetal death. Cochrane Database Syst Rev. 2010;14(4):CD004901.
   Google Scholar
• Wildschut H, Both MI, Medema S, et al. Medical methods for mid-trimester termination of pregnancy. Cochrane Database Syst Rev. 2011;19(1):CD005216.
   Google Scholar
• Royal College of Obstetricians and Gynaecologists. Best practice in abortion care. London: The College; 2022.
   Google Scholar
• Costescu D, Guilbert E. SOGC clinical practice guideline. Induced abortion: surgical abortion and second trimester medical methods. J Obstet Gynaecol Can. 2018;40(6):750–783.
   PubMedGoogle Scholar
• Guyatt GH, Oxman AD, Vist GE, GRADE Working Group, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–926.
   PubMed Web of Science ®Google Scholar
• Renner R, Ennis M, Guilbert E, et al. Second- and third-trimester medical abortion providers and services in 2019: results from the Canadian abortion provider survey. J Obstet Gynaecol Can. 2022;44(6):690–699.
   PubMedGoogle Scholar
• Dommergues M, Benachi A, Benifla J, et al. The reasons for termination of pregnancy in the third trimester. Br J Obstet Gynaecol. 1999;106(4):297–303.
   PubMedGoogle Scholar
• Cordier A, Thubert T, Dussaux C, et al. Evolution of third-trimester pregnancy terminations in France. Eur J Obstet Gynecol Reprod Biol. 2020;248:123–127.
   PubMedGoogle Scholar